0069-8140 : Xalkori 250 mg Oral Capsule


NDC: 0069-8140
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Xalkori
Dosage Form: Oral Capsule
Application #: NDA202570
Rev. Date: 


Appearance:


Markings: Pfizer;CRZ;250
Shapes:  Capsule
Colors:  Pink
Size (mm): 21
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Pfizer CRZ 250: (0069-8140) Xalkori 250 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0069-8140-20: 60 CAPSULE IN 1 BOTTLE (0069‑8140‑20)

Active Ingredients:

  • Crizotinib

Dosage Strength:

  • 250 mg

Inactive Ingredients:

  • Silicon Dioxide
  • Cellulose, Microcrystalline
  • Calcium Phosphate, Dibasic, Anhydrous
  • Magnesium Stearate
  • Gelatin
  • Titanium Dioxide
  • Ferric Oxide Red
  • Shellac
  • Propylene Glycol
  • Ammonia
  • Potassium Hydroxide
  • Ferrosoferric Oxide

Pharmaceutical Classes:

  • Cytochrome P450 2B6 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Kinase Inhibitor [EPC]
  • Organic Cation Transporter 1 Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Receptor Tyrosine Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-0251 Xalkori 20 mg Oral Capsule, Coated Pellets by Pfizer Laboratories Div Pfizer Inc
  • 0069-0507 Xalkori 50 mg Oral Capsule, Coated Pellets by Pfizer Laboratories Div Pfizer Inc
  • 0069-1500 Xalkori 150 mg Oral Capsule, Coated Pellets by Pfizer Laboratories Div Pfizer Inc
  • 0069-8141 Xalkori 200 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-8140 QR Code

< Prev: 0069-7810Next: 0069-8141 >

Related Discussions:

conceiving a baby while on Xalkori/Crizotinib
Hello, I am new to this forum and pleased to meet you all. My partner, a 27-year old man is being treated with Crizotini... 4 replies
Xalkori results
My husband has metastatic lung cancer and has been on Xalkori. The drug appears to be working (the cancer has not spread... 27 replies
Xalkori cost on Medicare--Mexico, Cananda, anything???
My mom was diagnosed with stage IV NSCLC with only BM two weeks ago. The day before she was to get her port for Carbo/Ta... 10 replies
xalkori and acid reflux/gerd
I have been on xalkori for about a year now; diagnosed with stage IV lung cancer that mets to the pancreas. Lately, I ha... 4 replies
xalkori after effects
I have been taking this drug for 5 weeks and am having almost no side effects except odema--swelling of the legs and han... 3 replies
Xalkori for thyroid cancer metastasis in lungs?
Hello my name is Erica & I was diagnosed with papillary thyroid cancer in 2005 at the age of 15. At the time I was d... 3 replies
Xalkori edema and lower intestinal tract
I started taking Xalkori about 9 weeks ago for stage IV ROS1 lung caner. My cough disappeared after the first pill so I ... 2 replies
xalkori side effects
My brother in law was just diagnosed with stage IV lung cancer. It has metastasized to his brain, liver, and bones. He s... 2 replies
Xalkori fatigue and weakness
I have been taking Xalkori since the end of May 2012. In the first 30 days, I had trouble keeping food down, lost 20 lbs... 2 replies
Xalkori Reviews
I have been taking Xalkori since the end of May 2012. In the first 30 days, I had trouble keeping food down, lost 20 lbs... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.